<DOC>
	<DOCNO>NCT02890589</DOCNO>
	<brief_summary>To assess strut coverage patient present acute myocardial infarction treat either SYNERGY stent Bioresorbable Vascular Scaffold , parallel group design .</brief_summary>
	<brief_title>Strut Coverage With SYNERGY Stents Bioresorbable Vascular Scaffold Acute Myocardial Infarction</brief_title>
	<detailed_description>Single center , simple-blind randomize controlled trial , compare SYNERGY stent BVS device parallel group design .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Chromium</mesh_term>
	<criteria>Acute coronary syndrome STelevation , One culprit lesion eligible percutaneous coronary intervention ( PCI ) stent implantation , Reference vessel measure 2.5 mm 3.75 mm per visual estimation , without extreme vessel tortuosity , thrombolysis myocardial infarction ( TIMI ) 3 flow stent deployment target vessel , Patient least 1 lesion eligible plan PCI next culprit lesion , Patient affiliate French national health care system , Patient agree participate full information study ( signature inform consent ) . Acute coronary syndrome STelevation , One culprit lesion eligible percutaneous coronary intervention ( PCI ) stent implantation , Reference vessel measure 2.5 mm 3.75 mm per visual estimation , without extreme vessel tortuosity , TIMI 3 flow stent deployment target vessel , Patient least 1 lesion eligible plan PCI next culprit lesion , Patient affiliate French national health care system , Patient agree participate full information study ( signature inform consent ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Acute coronary syndrome</keyword>
	<keyword>ST ( Software Test ) -elevation</keyword>
</DOC>